IQV IQVIA Holdings Inc. Загрузка... : Бычьи и медвежьи мнения аналитиков
Загрузка графика...
Лучшие сигналы
Лента
13:00
05 авг
05 авг
DSA bookings and book-to-bill hit their highest level in nearly four years (Q3 2022), signalling the start of an industry-wide recovery in preclinical demand, earlier than many expected. — Strong DSA demand may indicate a broader CRO recovery trend; competitors may also see improvements later in 2026.
Сред.
09:58
03 авг
03 авг
A news wire reports a broad list of price target increases from multiple banks across dozens.
A news wire reports a broad list of price target increases from multiple banks across dozens of stocks, with no explicit directional calls or personal market views expressed.
13:00
28 июл
28 июл
Exceptionally positive tone with all metrics exceeding guidance, strong bookings, improving market conditions, and raised full-year guidance across revenue, EBITDA, and EPS.
Выс.
03:01
06 мая
06 мая
The author compares current semiconductor mania to the COVID-era biopharma bubble.
The author compares current semiconductor mania to the COVID-era biopharma bubble, warning that overextrapolation of innovation led to massive losses, implying similar risk for semis now.
Выс.
02:56
06 мая
06 мая
The author compares current semiconductor mania to the COVID-era life sciences bubble.
The author compares current semiconductor mania to the COVID-era life sciences bubble, warning that overhyped assumptions could lead to a similar crash.
Выс.
13:00
05 мая
05 мая
Management raised EPS guidance and highlighted strong acceleration in organic growth, record pipelines, and positive demand indicators, signaling confidence in continued momentum.
Выс.
00:52
03 апр
03 апр
The tweet implies a negative outlook for contract research organizations.
Выс.
22:00
04 мар
04 мар
Veeva is taking market share from IQVIA in the CRM space for top-20 pharma accounts.
Выс.
04:33
17 фев
17 фев
A sell-side analyst has lowered their price target on IQV.
A sell-side analyst has lowered their price target on IQV, signaling a bearish forward-looking view on the stock's potential.
Сред.
14:00
05 фев
05 фев
Guidance for 2026 is positive, with expected revenue growth of ~6% at the midpoint (~$17.23B). The company expects the demand environment to continue improving, driven by stabilization in biotech funding and strong demand for its AI-enabled offerings.
Выс.
22:00
20 ноя
20 ноя
Veeva expects Crossix to potentially match the size of the entire CRM suite by 2030, signaling significant growth in digital marketing measurement. — This implies that the shift to digital marketing measurement is accelerating at the expense of traditional CRM spend, impacting both IQVIA and Salesforce.
Выс.
Об аналитическом покрытии IQV
Buzzberg отслеживает IQV (IQVIA Holdings Inc.) в 4 источниках. Бычьих сигналов: 0, медвежьих: 0, от 8 аналитиков. Сентимент разделён поровну. Всего отслеживается 11 торговых идей. Последние спикеры: Birgit Girshick, DeItaone, Ari Bousbib.